Search

In celebration of our 100th issue of Capsid & Tail, we launched a survey called State of Phage 2020! We created this survey to help us all better understand the phage research community globally, including what kind of phages people are col

The J. Craig Venter Institute in Rockville, MD is hiring a postdoc to develop improved reverse genetic tools for viruses, leading to a more complete understanding of viruses that lack robust genetic tools, such as agricultural pathogens and

The University of Exeter (Exeter, UK) is hiring a postdoc to support the work of Dr. Wolfram Moebius. The successful applicant will investigate phage evolution within biofilms.

CAMRIS is seeking a Microbiology and Molecular Genetics Scientist, a phage biologist, and a phage molecular biologist to support the Walter Reed Army Istitute of Research (WRAIR) Wound Infection Department.

Would you like to build phage de novo for medical, environmental, and agricultural applications? Help us change the future of science! Looking for a talented molecular biologist that is interested in viruses, phage, and synthetic biology! O

Locus Biosciences signed a contract with CARB-X to advance a $14 million precision medicine program to develop their crPhage™ product, which targets Klebsiella pneumoniae infections.

The C-SNIPER project (Campylobacter-Specific Nullification via Innovative Phage-mediated Enteropathogen Reduction), led by AZTI (a technology center in Spain) received funding from the European Institute of Innovation & Technology. The proj

Michela Gambino (University of Copenhagen) and colleagues published a new review in Current Opinion in Biotechnology on modernizing phage-based control of zoonotic pathogens in food and animal production. They suggest a holistic approach bu

Sofia Dahlman (Monash University) and colleagues published a new review in Current Opinion in Biotechnology on phages to shape the gut microbiota. They discuss current understanding of phages within the gut (from infancy, to adulthood, to d

Some elements, termed phage-plasmids, are known to be both plasmids and phages. Eugen Pfeifer (Institut Pasteur) and colleagues screened 14,000 phages and plasmids and found 780 phage-plasmids across very diverse bacterial phyla, suggesting

💯 It’s our 100th issue and 2nd birthday!! Thanks so much to all of you for reading and sharing Capsid & Tail; we wouldn’t have gotten this far without your support! This week, Clément Girardot interviewed University of Leicester Professor

In celebration of our 100th issue of Capsid & Tail, we launched a survey called State of Phage 2020! We created this survey to help us all better understand the phage research community globally, including what kind of phages people are col

The Levin lab at Emory University (Atlanta, Georgia) is hiring a postdoctoral research associate to do jointly theoretical and experimental research on the population and evolutionary biology of bacteria and bacteriophage. To inquire, pleas

Sandia National Laboratories (Albuquerque, New Mexico) is hiring a postdoctoral scientist to study the interaction of bacteria with noble gases, to use phage-assisted continuous evolution to evolve proteins for biosensing applications, and

The Fineran lab (University of Otago, New Zealand) has openings for PhD students to study phages and CRISPR. Due to border restrictions, applicants must already be in New Zealand.

General Dynamics Information Technology (Silver Spring, Maryland) has openings for a phage immunologist, a phage biologist, and a phage molecular biologist to work on a phage therapy project for the Wound Infections Department of the Walter

The third iVoM event will be Thursday, November 19, 4pm GMT, and the theme will be "Virus-host interaction: overcoming cell barriers". It will feature talks by: Martin J. Loessner (ETH Zurich, Zurich, Switzerland) Carlos São-José (Universi

The third iVoM event will be Thursday, November 19, 4pm GMT, and the theme will be "Virus-host interaction: overcoming cell barriers". It will feature talks by: Martin J. Loessner (ETH Zurich, Zurich, Switzerland) Carlos São-José (Universi

Adaptive Phage Therapeutics has deployed their PhageBank™ in Texas to treat COVID-19 patients suffering from life-threatening carbapenem resistant Acinetobacter baumannii (CRAB). Eight of these patients have so far received PhageBank™ thera

BiomX has announced the dosing of their first subject in their Phase 1a clinical study testing the safety, pharmacokinetics and oral delivery of a phage therapy candidate for treatment of Inflammatory Bowel Disease. Results are expected in